135 related articles for article (PubMed ID: 38646861)
21. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients.
Fuente MJ; Sabat M; Roca J; Lauzurica R; Fernández-Figueras MT; Ferrándiz C
Br J Dermatol; 2003 Dec; 149(6):1221-6. PubMed ID: 14674900
[TBL] [Abstract][Full Text] [Related]
22. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
Ge L; Chee SN; Robledo KP; Lowe P
Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Melanoma in Renal Transplant Recipients.
Ascha M; Ascha MS; Tanenbaum J; Bordeaux JS
JAMA Dermatol; 2017 Nov; 153(11):1130-1136. PubMed ID: 28746700
[TBL] [Abstract][Full Text] [Related]
25. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
de Fijter JW
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
[TBL] [Abstract][Full Text] [Related]
26. Association Between HLA Type and Skin Cancer in Kidney Transplant Recipients.
Cegielska A; Dębska-Ślizień A; Moszkowska G; Imko-Walczuk B; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1608-10. PubMed ID: 27496455
[TBL] [Abstract][Full Text] [Related]
27. Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients.
Fania L; Abeni D; Esposito I; Spagnoletti G; Citterio F; Romagnoli J; Castriota M; Ricci F; Moro F; Perino F; Mazzanti C; De Simone C; Peris K
G Ital Dermatol Venereol; 2020 Oct; 155(5):669-675. PubMed ID: 30251802
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Dietary Patterns and Risk of Keratinocyte Cancers in Kidney Transplant Recipients: Prospective Cohort Study.
Shao E; Green AC; Miura K
Dermatology; 2021; 237(6):1029-1034. PubMed ID: 32966976
[TBL] [Abstract][Full Text] [Related]
29. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
30. A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Eckembrecher DG; Eckembrecher FJ; Camacho I; Shah H; Dave Y; Patel S; Nouri K
Arch Dermatol Res; 2023 Nov; 315(9):2491-2503. PubMed ID: 37256379
[TBL] [Abstract][Full Text] [Related]
31. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients.
Burke MT; Morais C; Oliver KA; Lambie DL; Gobe GC; Carroll RP; Staatz CE; Sinnya S; Soyer HP; Winterford C; Haass NK; Campbell SB; Isbel NM
Am J Clin Pathol; 2015 Apr; 143(4):514-26. PubMed ID: 25780003
[TBL] [Abstract][Full Text] [Related]
32. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
Opelz G; Unterrainer C; Süsal C; Döhler B
Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
[TBL] [Abstract][Full Text] [Related]
35. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
[TBL] [Abstract][Full Text] [Related]
36. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
37. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort.
Stapleton CP; Birdwell KA; McKnight AJ; Maxwell AP; Mark PB; Sanders ML; Chapman FA; van Setten J; Phelan PJ; Kennedy C; Jardine A; Traynor JP; Keating B; Conlon PJ; Cavalleri GL
Am J Transplant; 2019 Mar; 19(3):801-810. PubMed ID: 30085400
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
[TBL] [Abstract][Full Text] [Related]
39. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
40. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]